ARS Pharmaceuticals, Inc. (SPRY) has 23 open-market insider trades by 12 insiders since 2022. The most active filer is Justin Chakma.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Dir10% Owner | — | 2 | $45.9M | 2024-03-27 |
| James E. Flynn | 10% Owner | — | 1 | $27.3M | 2025-06-27 |
| Peter A. Thompson | Dir | — | 3 | $20.8M | 2024-08-26 |
| RA Capital Healthcare Fund LP | Dir | — | 1 | $16.4M | 2023-09-21 |
| Justin Chakma | — | — | 6 | $12.8M | 2025-11-12 |
| Deerfield Private Design Fund III, L.P. | 10% Owner | — | 1 | $10.8M | 2024-11-12 |
| Orbimed Capital LLC | Dir | — | 1 | $5.1M | 2024-08-22 |
| Alexander A. Fitzpatrick | CLO | — | 2 | $3.4M | 2026-06-12 |
| Brent L. Saunders | Dir | — | 1 | $1.7M | 2025-05-20 |
| Kathleen D. Scott | CFO | — | 2 | $756K | 2025-08-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alexander A. Fitzpatrick | CLO | Sell | $34K | 2026-06-12 |
| Eric Karas | CCO | Sell | $250K | 2026-06-12 |
| Brian Dorsey | COO | Sell | $380K | 2025-11-13 |
| Justin Chakma | — | Sell | $2.7M | 2025-11-12 |
| Kathleen D. Scott | CFO | Sell | $188K | 2025-08-21 |
| Richard E. Lowenthal | CEO & President | Sell | $725K | 2025-08-21 |
Companies that share insiders with SPRY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sarina Tanimoto | — | Sell | $1.4M | 2025-08-19 |
| Eric Karas | CCO | Sell | $510K | 2025-07-01 |
| James E. Flynn | 10% Owner | Sell | $27.3M | 2025-06-27 |
| Eric Karas | CCO | Sell | $240K | 2025-06-18 |
| Kathleen D. Scott | CFO | Sell | $705K | 2025-05-20 |
| Brent L. Saunders | Director | Sell | $1.7M | 2025-05-20 |
| Alexander A. Fitzpatrick | CLO | Sell | $2.9M | 2025-05-20 |
| Laura Shawver | Director | Sell | $1.2M | 2025-04-07 |
| Eric Karas | CCO | Sell | $140K | 2025-03-20 |